|Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).|
MC Bene, G Castoldi, W Knapp, WD Ludwig, E Matutes, A Orfao, ...
Leukemia 9 (10), 1783-1786, 1995
|Long-term cause-specific mortality of patients treated for Hodgkin’s lymphoma|
BMP Aleman, AW van den Belt-Dusebout, WJ Klokman, MB van’t Veer, ...
J Clin Oncol 21, 3431-9, 2003
|Late cardiotoxicity after treatment for Hodgkin lymphoma|
BMP Aleman, AW van den Belt-Dusebout, ML De Bruin, MB van't Veer, ...
Blood 109 (5), 1878-1886, 2007
|Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a …|
MHJ Van Oers, R Klasa, RE Marcus, M Wolf, E Kimby, RD Gascoyne, ...
Blood 108 (10), 3295-3301, 2006
|Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease|
LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ...
Jama 290 (4), 465-475, 2003
|Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years|
GM Dores, C Metayer, RE Curtis
Oncology Times 24 (12), 89-90, 2002
|Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood|
FE van Leeuwen, WJ Klokman, MB Veer, A Hagenbeek, ADG Krol, ...
Journal of Clinical Oncology 18 (3), 487-487, 2000
|Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease|
C Fermé, H Eghbali, JH Meerwaldt, C Rieux, J Bosq, F Berger, T Girinsky, ...
New England Journal of Medicine 357 (19), 1916-1927, 2007
|Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma|
LB Travis, D Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ...
Journal of the National Cancer Institute 97 (19), 1428-1437, 2005
|Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease|
FE van Leeuwen, WJ Klokman, M Stovall, EC Dahler, MB van’t Veer, ...
Journal of the National Cancer Institute 95 (13), 971-980, 2003
|Second cancers among long-term survivors of Hodgkin’s disease diagnosed in childhood and adolescence|
C Metayer, CF Lynch, EA Clarke, B Glimelius, H Storm, E Pukkala, ...
Journal of Clinical Oncology 18 (12), 2435-2443, 2000
|Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes|
ML De Bruin, J Sparidans, MB van't Veer, EM Noordijk, MWJ Louwman, ...
Journal of Clinical oncology 27 (26), 4239-4246, 2009
|Involved-field radiotherapy for advanced Hodgkin's lymphoma|
BMP Aleman, JMM Raemaekers, U Tirelli, R Bortolus, MB Van't Veer, ...
New England Journal of Medicine 348 (24), 2396-2406, 2003
|Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study|
MHJ Van Oers, M Van Glabbeke, L Giurgea, R Klasa, RE Marcus, M Wolf, ...
Journal of clinical oncology 28 (17), 2853, 2010
|Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification|
E Matutes, WF Pickl, M Van'T Veer, R Morilla, J Swansbury, H Strobl, ...
Blood, The Journal of the American Society of Hematology 117 (11), 3163-3171, 2011
|High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non–AIDS-related primary central nervous system lymphoma: European Organization for Research …|
PMP Poortmans, HC Kluin-Nelemans, H Haaxma-Reiche, M Van’t Veer, ...
Journal of Clinical Oncology 21 (24), 4483-4488, 2003
|The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias|
MC Béné, M Bernier, RO Casasnovas, G Castoldi, W Knapp, F Lanza, ...
Blood, The Journal of the American Society of Hematology 92 (2), 596-599, 1998
|Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma|
ML De Bruin, LDA Dorresteijn, MB van't Veer, ADG Krol, HJ Van der Pal, ...
JNCI: Journal of the National Cancer Institute 101 (13), 928-937, 2009
|CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies|
JEC Bromberg, DA Breems, J Kraan, G Bikker, B van der Holt, PS Smitt, ...
Neurology 68 (20), 1674-1679, 2007
|Lung cancer after treatment for Hodgkin's disease: focus on radiation effects|
ES Gilbert, M Stovall, M Gospodarowicz, FE Van Leeuwen, M Andersson, ...
Radiation research 159 (2), 161-173, 2003